Literature DB >> 11016474

The role of telomerase in breast cancer.

K Mokbel1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11016474     DOI: 10.1053/ejso.1999.0932

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


× No keyword cloud information.
  6 in total

1.  Serum human telomerase reverse transcriptase: a novel biomarker for breast cancer diagnosis.

Authors:  Mahendar Porika; Radhika Tippani; Sekhar R Bollam; Sree Divya Panuganti; Christopher Thamidala; Sadanandam Abbagani
Journal:  Int J Clin Oncol       Date:  2011-04-28       Impact factor: 3.402

2.  Antiproliferative effects of cucurbitacin B in breast cancer cells: down-regulation of the c-Myc/hTERT/telomerase pathway and obstruction of the cell cycle.

Authors:  Suwit Duangmano; Sumana Dakeng; Weena Jiratchariyakul; Apichart Suksamrarn; Duncan R Smith; Pimpicha Patmasiriwat
Journal:  Int J Mol Sci       Date:  2010-12-22       Impact factor: 5.923

3.  The expression of hTR and hTERT in human breast cancer: correlation with clinico-pathological parameters.

Authors:  Saied Hosseini-Asl; Morteza Atri; Mohammad H Modarressi; Mohamed Salhab; Kefah Mokbel; Parvin Mehdipour
Journal:  Int Semin Surg Oncol       Date:  2006-08-22

4.  siRNA inhibition of telomerase enhances the anti-cancer effect of doxorubicin in breast cancer cells.

Authors:  Xuejun Dong; Anding Liu; Cindy Zer; Jianguo Feng; Zhuan Zhen; Mingfeng Yang; Li Zhong
Journal:  BMC Cancer       Date:  2009-05-05       Impact factor: 4.430

5.  There is no correlation between c-Myc mRNA expression and telomerase activity in human breast cancer.

Authors:  Katharine L Kirkpatrick; Robert F Newbold; Kefah Mokbel
Journal:  Int Semin Surg Oncol       Date:  2004-05-06

6.  The mRNA expression of hTERT in human breast carcinomas correlates with VEGF expression.

Authors:  Katharine L Kirkpatrick; Robert F Newbold; Kefah Mokbel
Journal:  J Carcinog       Date:  2004-01-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.